Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

55
Prof. Aboubakr Elnashar Benha University Hospital, Egypt

Transcript of Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Page 1: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Prof. Aboubakr ElnasharBenha University Hospital, Egypt

Page 2: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Prediction:Routine urine analysis•Prevention:Chocolate

Page 3: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Outline

IntroductionPredictionPrevention

Page 4: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Cochrane Systematic ReviewGold Standard' for high-quality systematic reviews

Page 5: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Preeclampsia: Hypertension associated with proteinuria.

Page 6: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Pathogenesis: •unknown (Barton& Sibai, 2008).

Impaired trophoblast differentiation& invasion Placental & endothelial dysfunction Immune maladaptation to paternal AgsExaggerated systemic inflam response.

Page 7: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Pathogenesis: •Differs with various risk factors: PG Vs MG with previous PEpreexisting vas dispreexisting DM or multifetal gestation.

Page 8: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

In PE: Impaired trophoblast differentiation & invasion

Page 9: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Placental and endothelial dysfunction

Page 10: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

PREDICTION OF PE

• Why prediction is important?• The ideal screening test • Methods I. Preconception factors II. Pregnancy-Related Factors 1. Risk factors 2. Markers

Page 11: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Why prediction is important:1.The risk for recurrent PE can be as high as 65% (Barton&

Sibai, 2008).

2.PE is associated with substantial maternal& perinatal complications

Page 12: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

The ideal Screening test: SimpleNoninvasiveRapidInexpensiveEasy to perform early in pregnancyHighly sensitivity & predictive.

Page 13: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

I. Preconception factors1st step in the management of a woman with a history of PE is to conduct a detailed evaluation of potential risk factors (Barton& Sibai, 2008).

Page 14: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Preconceptional Risk FactorsRates of preeclampsia depend on: severity of underlying

complications &

combinations of risk factors . Risk factorsRisk%

Chronic hypertension/renal disease15-40

Pre gestational DM10-35

Connective tissue disease (lupus, rheumatoid arthritis)

10-20

Thrombophilia (acquired or congenital) 10-40

Obesity/insulin resistance 10-15

Age older than 40 y10-20

Limited sperm exposure10-35

Family history of preeclampsia/ cardiovascular disease

10-15

Woman born as SFGA1.5 fold

Adverse outcome in a previous pregnancy: IUGR, ab placentae, IUFD

2-3 fold

Page 15: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

II. Pregnancy-Related FactorsRegular antenatal care is mandatory for the prevention & early detection of PE .

Risk factors: Magnitude of risk depends on the number of factors

Hydrops/hydropic degeneration of the placentaMultifetal gestationUnexplained FGRGestational hypertensionUTIPeriodontal infectionMarkersBiophysicalBiochemical

Page 16: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Markers Many Based on: pathophysiological abnormalities

Page 17: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•SCREENING TESTS FOR PE (WHO, 2004)

I. Placental perfusion & vascular resistance dysfunctionMean arterial blood pressureRoll over test Doppler ultrasound Isometric exercise test Intravenous infusion of angiotensin II Platelet angiotensin II binding Platelet calcium response to arginine vasopressin Renin 24-hour ambulatory blood pressure monitoring

II. Fetoplacental unit dysfunctionHuman chorionic gonadotropin Alpha fetoprotein Estriol Inhibin A Pregnancy-associated plasma protein A Activin A Corticotropin release hormone

Page 18: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

III. Renal dysfunction Serum uric acid Microalbuminuria Urinary calcium excretion Urinary kallikrein Microtransferrinuria N-acetyl- glucosarninidase

Platelet countPlatelet activation and endothelial cell adhesion moleculesProstacyclinCytokinesIsoprostanes, Antiphospholipid antibodies, Placenta growth factorHematocritAntithrombin IllCalciumTransferrinAtrial natriuretic peptide

Fibronectin Endothelin Thromboxane Homocysteine Serum lipids Insulin resistance Plasminogen activator inhibitor Leptin Total proteins Magnesium Ferritin Haptoglobin microglobulin Genetic markers

IV. Endothelial& oxidant stress dysfunction

Page 19: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

I. Biophysical•Mean arterial pressure•(2D BP+S BP)/3•Better predictor of PE than S& D BP (BMJ 200817;336:111; Meta-analysis of 34 RCT)

2nd trimester MA BP ≥ 90 mm Hg had +ve LR 3.5 and –ve LR 0.46

•BP remains the cornerstone of early diagnosis although it has limitations:measurement errors associated with sphygmomanometereffect of maternal posture on BP in pregnant women}.

Page 20: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Repeated routine urinalysis throughout pregnancy NOT useful for predicting PE(JAMA 2003: 12;289(10):1220)

Page 21: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Uterine artery Doppler ultrasound•}impaired trophoblastic invasion of the spiral arteries: reduction in uteroplacental blood flow}•High pulsatility index and/or Notch in 1st & 2nd trimesters: poor predictor of PE(Papgeorghiou & Leslie, 2007)

Uterine artery Doppler plus biochemical markers•Promising results •Current data do not support this combination for routine screening for PE (Barton& Sibai, 2008).

Page 22: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Diastolic Notch in uterine artery waveform

Page 23: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

The Roll over testNot of value in predicting PE

)Mahomed &Lasiende,1990(

Page 24: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

II. Biochemical Markers

Angiogenic factors before & after the onset of PE(Barton& Sibai, 2008).

Serum placental growth factor: reducedSoluble fms-like tyrosine kinase: elevatedEndoglin: elevated

Page 25: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Conclusion•BP remains the cornerstone of early diagnosis •MarkersReliability is inconsistentMany suffer from poor specificity & predictive values.None provided a cutoff value that could be clinically useful for the prediction of PE (Widmer et al, 2007).

Page 26: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Currently: There is no clinically useful screening test to predict PE (WHO, 2004)

Page 27: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

PrimarySecondary

Prevention of PE

Page 28: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Primary prevention•Avoiding occurrence of the disease•Obese:achieve an ideal b wt before conception (Villamor& Cnattingius, 2006)

No RCT•Ch hypertension:Control BP before conception. No RCT

Page 29: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Pregestational DM:-Complete her family as early as possible & before vascular complications develop -Control DM before conception & throughout pregnancy

Page 30: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Secondary•Breaking off the disease process before emergence of obvious clinical disease•{Etiology of the disease is unknown} •To correct theoretical pathophysiology•I. Non pharmacologicalII. Nutritional III. Pharmacological

Page 31: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

I. Non pharmacological1. Daily Bed restRest for 4-6 h/dMay reduce risk of PE for women with normal BP (level 2 evidence) (Cochrane Library 2006 Issue 2:CD005939)

Page 33: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

3. Regular prenatal exercise•May prevent or oppose progression (Weissgerber et al, 2004)

•{Stimulation of placental growthReduction of oxidative stressReversal of maternal endothelial dysfunction}. •Insufficient evidenceModerate intensity regular aerobic exercise(Cochrane Library 2006 Issue 2:CD005942) Aerobic exercise =cardiovascular exercise=any sustained rhythmic activity that involves large muscle groups: makes the lungs work harder as the body's need for oxygen is increased.

Page 34: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

•Stretching exercises are more effective at reducing the risk of PE than walking (University of North Carolina,2008)

Page 35: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Smoking: Reduced risk for PE (Sibai et al, 2005).

{Nicotine inhibition of interleukin-2 & tumor necrosis factorEffects of nicotine on angiogenic proteins}. Smoking: abnormal fetal growthpreterm birthAbruptionAdverse effects on maternal health.

Page 37: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

2. Increasing dietary protein & energy intake RCT: no benefit

•5 or more servings of chocolate/w in 3rd trimester:40% reduction(Triche, 2008; Epidemiology .19:459-464), Yale University

{Chocolate, especially dark chocolate, is rich in theobromine: stimulates the heart, relaxes smooth muscle & dilates blood vessels, and has been used to treat chest pain, high blood pressure}

Page 40: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

6. Fish Oil Supplementation •Observational studies: beneficial effects •{inhibition of platelet thromboxane A2 without affecting prostacyclin: shifting the balance toward a reduced platelet aggregation and increased VD}. •RCT: No benefit (Olsen et al, 2000)

•High doses: increase the risk of PIH(Olafasdottir et al, 2006).

•Not recommended for the prevention of PE

Page 41: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

5. Weight Reduction •Although obesity is a known risk factor, there is no evidence that limiting wt gain during pregnancy; reduces its occurrence. •Wt reduction is not recommended during pregnancy even in obese women (Kramer, 2004)

Page 42: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

III. Pharmacological

1 .Low-dose Aspirin •{inhibits biosynthesis of platelet thromboxane A2 with little effect on vascular prostacyclin production: altering the balance in favor of prostacyclin}. •(50-150 mg/day) For women with a previous history of hypertension or PE (n=6,107):Small to moderate benefits, safe. level 2 evidence (Cochrane Library 2007 Issue 2:CD004659)

Page 43: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

2. Low-dose Aspirin/Heparin•History of severe preterm PE & LBW infants.(Sergio et al, 2006)

•Lower incidence of PE (3Vs 30%) Greater gestational age at deliveryHigher birth wt

Page 44: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

3. Calcium Supplementation •Reduces the risk of PIH, particularly in populations that have diets deficient in calcium level 1 evidence (Cochrane Syt review , 2006)

•The relationship between cal & risk of PIH is inconsistent& inconclusiveThe relationship between cal & the risk of PE is highly unlikely.Evidence-based review by FDA (2007)

Page 45: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

4. Antihypertensive Drugs •Mild to moderate hypertension: Halving in the risk of developing severe hypertensionNo difference in the risk of developing PE or proteinuria (Cochrane syst review, 2007)

Page 46: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

5. Diuretics •No reduction in the incidence of PE or perinatal mortality•May have deleterious effects: reduced renal & placental perfusion. (Cochrane Library 2007 Issue 1:CD004451)

Page 47: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

6 .Antioxidant supplementation may not affect risk of PE or clinical outcomes

level 2 evidence

)Cochrane Library 2008 Issue 1:CD004227(

Page 48: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

7 .Concomitant Vit C& E supplementation •{PET: imbalance of oxidant & antioxidant activity: multiorgan endothelial dysfunction}. •Vit C (1,000 mg/d) plus vit E (400 IU/ d)•Did not prevent PElevel 2 evidence (Obstet Gynecol 2007 Dec;110(6):1311)•May increases rate of LBW infants& might be associated with higher rate of SBlevel 2 evidence (Lancet 2006 Apr 8;367(9517):1145

Page 49: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

8. Magnesium •{Mg is beneficial for the prevention & tt of severe PE & EDecreased intracellular Mg in PE} •No effect•(365 mg& 500 mg).Cochrane syst review, 2004

Page 50: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

9. Folic acid& other B-vits •{Deficiency of vit B2 may cause biochemical changes simulating abnormalities of PE}•No evidence that any of B vits can prevent PE (Shrama& Mittal, 2006).

Page 51: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

10. Zinc supplementation •{Zinc concentrations are reduced in PE}•RCT: No benefit(Jonsson et al, 1996)

Page 52: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

11. Nitric oxide Insufficient evidence for preventing PECochrane Library 2007 Issue 2:CD006490

Page 53: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

12. Progesterone Insufficient evidence for preventing PE Cochrane review, 2006

Page 54: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

ConclusionRegular antenatal care is mandatory for the prevention & early detection of PE. For prevention of PEBed restReduction of job stressHigh dietary fiber intake Low dose aspirinLow dose aspirin/heparinCa supplementation

Page 55: Prof. Aboubakr Elnashar Benha University Hospital, Egypt.

Thank YouThank YouThank YouThank YouAboubakr Elnashar